- Patent Title: Compounds for inhibiting cell proliferation in EGFR-driven cancers
-
Application No.: US13464921Application Date: 2012-05-04
-
Publication No.: US09834518B2Publication Date: 2017-12-05
- Inventor: David C. Dalgarno , Wei-Sheng Huang , William C. Shakespeare , Yihan Wang , Xiaotian Zhu
- Applicant: David C. Dalgarno , Wei-Sheng Huang , William C. Shakespeare , Yihan Wang , Xiaotian Zhu
- Applicant Address: US MA Cambridge
- Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: C07D239/46
- IPC: C07D239/46 ; C07D239/50 ; C07D401/12 ; C07D403/12 ; C07D413/12 ; A61K31/4025 ; A61K31/444 ; A61K31/4523 ; A61K31/506 ; A61K31/505 ; A61K31/538 ; A61K31/553 ; A61P35/00 ; C07D239/48 ; C07D405/12
Abstract:
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: wherein the variables are as defined herein.
Public/Granted literature
- US20120316135A1 Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers Public/Granted day:2012-12-13
Information query
